785 related articles for article (PubMed ID: 20926534)
1. Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome.
Hutchison SK; Stepto NK; Harrison CL; Moran LJ; Strauss BJ; Teede HJ
J Clin Endocrinol Metab; 2011 Jan; 96(1):E48-56. PubMed ID: 20926534
[TBL] [Abstract][Full Text] [Related]
2. The impact of intensified exercise training on insulin resistance and fitness in overweight and obese women with and without polycystic ovary syndrome.
Harrison CL; Stepto NK; Hutchison SK; Teede HJ
Clin Endocrinol (Oxf); 2012 Mar; 76(3):351-7. PubMed ID: 21711376
[TBL] [Abstract][Full Text] [Related]
3. The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome.
Thomson RL; Buckley JD; Noakes M; Clifton PM; Norman RJ; Brinkworth GD
J Clin Endocrinol Metab; 2008 Sep; 93(9):3373-80. PubMed ID: 18583464
[TBL] [Abstract][Full Text] [Related]
4. Exploring factors related to changes in body composition, insulin sensitivity and aerobic capacity in response to a 12-week exercise intervention in overweight and obese women with and without polycystic ovary syndrome.
Scott D; Harrison CL; Hutchison S; de Courten B; Stepto NK
PLoS One; 2017; 12(8):e0182412. PubMed ID: 28771628
[TBL] [Abstract][Full Text] [Related]
5. Pigment epithelium-derived factor, insulin sensitivity, and adiposity in polycystic ovary syndrome: impact of exercise training.
Joham AE; Teede HJ; Hutchison SK; Stepto NK; Harrison CL; Strauss BJ; Paul E; Watt MJ
Obesity (Silver Spring); 2012 Dec; 20(12):2390-6. PubMed ID: 22641183
[TBL] [Abstract][Full Text] [Related]
6. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.
Stepto NK; Cassar S; Joham AE; Hutchison SK; Harrison CL; Goldstein RF; Teede HJ
Hum Reprod; 2013 Mar; 28(3):777-84. PubMed ID: 23315061
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein before and after weight loss in overweight women with and without polycystic ovary syndrome.
Moran LJ; Noakes M; Clifton PM; Wittert GA; Belobrajdic DP; Norman RJ
J Clin Endocrinol Metab; 2007 Aug; 92(8):2944-51. PubMed ID: 17504892
[TBL] [Abstract][Full Text] [Related]
8. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Macut D; Panidis D
Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
[TBL] [Abstract][Full Text] [Related]
9. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
[TBL] [Abstract][Full Text] [Related]
10. Serum pigment epithelium-derived factor is elevated in women with polycystic ovary syndrome and correlates with insulin resistance.
Yang S; Li Q; Zhong L; Song Y; Tian B; Cheng Q; Qing H; Xia W; Luo M; Mei M
J Clin Endocrinol Metab; 2011 Mar; 96(3):831-6. PubMed ID: 21209034
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study.
Panidis D; Tziomalos K; Misichronis G; Papadakis E; Betsas G; Katsikis I; Macut D
Hum Reprod; 2012 Feb; 27(2):541-9. PubMed ID: 22144419
[TBL] [Abstract][Full Text] [Related]
12. Randomized comparison of the influence of dietary management and/or physical exercise on ovarian function and metabolic parameters in overweight women with polycystic ovary syndrome.
Nybacka Å; Carlström K; Ståhle A; Nyrén S; Hellström PM; Hirschberg AL
Fertil Steril; 2011 Dec; 96(6):1508-13. PubMed ID: 21962963
[TBL] [Abstract][Full Text] [Related]
13. Obesity and insulin resistance increase plasma viscosity in young women with polycystic ovary syndrome.
Vervita V; Saltamavros AD; Adonakis G; Tsapanos V; Decavalas G; Georgopoulos NA
Gynecol Endocrinol; 2009 Oct; 25(10):640-6. PubMed ID: 19557593
[TBL] [Abstract][Full Text] [Related]
14. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
15. Exercise decreases anti-müllerian hormone in anovulatory overweight women with polycystic ovary syndrome: a pilot study.
Moran LJ; Harrison CL; Hutchison SK; Stepto NK; Strauss BJ; Teede HJ
Horm Metab Res; 2011 Dec; 43(13):977-9. PubMed ID: 21989557
[TBL] [Abstract][Full Text] [Related]
16. Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome.
Ujvari D; Hulchiy M; Calaby A; Nybacka Å; Byström B; Hirschberg AL
Hum Reprod; 2014 Jul; 29(7):1526-35. PubMed ID: 24842895
[TBL] [Abstract][Full Text] [Related]
17. Effects of exercise and group counselling on body composition and VO2max in overweight women with polycystic ovary syndrome.
Roessler KK; Birkebaek C; Ravn P; Andersen MS; Glintborg D
Acta Obstet Gynecol Scand; 2013 Mar; 92(3):272-7. PubMed ID: 23237575
[TBL] [Abstract][Full Text] [Related]
18. The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome.
Panidis D; Tziomalos K; Papadakis E; Chatzis P; Kandaraki EA; Tsourdi EA; Katsikis I
Clin Endocrinol (Oxf); 2014 Mar; 80(3):432-8. PubMed ID: 23909452
[TBL] [Abstract][Full Text] [Related]
19. Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women.
Möhlig M; Weickert MO; Ghadamgadai E; Machlitt A; Pfüller B; Arafat AM; Pfeiffer AF; Schöfl C
Eur J Endocrinol; 2007 Aug; 157(2):195-200. PubMed ID: 17656598
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D in polycystic ovary syndrome: Relationship to obesity and insulin resistance.
Joham AE; Teede HJ; Cassar S; Stepto NK; Strauss BJ; Harrison CL; Boyle J; de Courten B
Mol Nutr Food Res; 2016 Jan; 60(1):110-8. PubMed ID: 26255991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
